Genome-free hepatitis B virion levels in patient sera as a potential marker to monitor response to antiviral therapy.
about
Molecular biology of hepatitis B virus infectionImportin β Can Bind Hepatitis B Virus Core Protein and Empty Core-Like Particles and Induce Structural ChangesAn Aptamer against the Matrix Binding Domain on the Hepatitis B Virus Capsid Impairs Virion FormationThe Dual Role of an ESCRT-0 Component HGS in HBV Transcription and Naked Capsid Secretion.Hepatitis B Virus Covalently Closed Circular DNA Formation in Immortalized Mouse Hepatocytes Associated with Nucleocapsid Destabilization.A novel pyridazinone derivative inhibits hepatitis B virus replication by inducing genome-free capsid formationIn situ analysis of intrahepatic virological events in chronic hepatitis B virus infection.Complete and Incomplete Hepatitis B Virus Particles: Formation, Function, and Application.Clinical relevance of the study of hepatitis B virus covalently closed circular DNA.Capsid Phosphorylation State and Hepadnavirus Virion SecretionDetection of Hepatitis B Virus Particles Released from Cultured Cells by Particle Gel AssayCell-Free Hepatitis B Virus Capsid Assembly Dependent on the Core Protein C-Terminal Domain and Regulated by PhosphorylationCharacterization of hepatitis B virus surface antigen variability and impact on HBs antigen clearance under nucleos(t)ide analogue therapy.Liver sampling: a vital window into HBV pathogenesis on the path to functional cure.Hepatitis B core protein as a therapeutic target.Common and Distinct Capsid and Surface Protein Requirements for Secretion of Complete and Genome-free Hepatitis B Virions.Multiple roles of core protein linker in hepatitis B virus replication.
P2860
Q28083478-6D92C6E4-985B-495D-926C-D31AA8B6543BQ28553490-0F4D7EF0-9223-4746-9DA0-451E7BF6862BQ35681412-11D0EFDC-9F93-442D-BB28-B87D5723E48BQ35797289-03FE3CBB-72E5-49ED-B78B-2F1C21626B77Q35913871-BF64F73F-7917-4305-ACC9-F18CC2D803F7Q36158466-BA222888-A319-4F18-B71C-C2EFC8A09952Q36618614-1E41B763-37D1-4D69-A0A1-96ED97DA81F3Q37727852-423E77BB-C721-4EB3-96C1-6A878B7C3C6EQ38685587-11F9B654-6F50-4D10-8EE0-7DEBC4682F12Q38715334-13A1D2B2-867B-4D87-887E-F62E1F07623BQ40409336-09541339-2721-403F-AE76-452E7F85CCFCQ40801347-39ADD7DB-4C7C-4BF4-B90F-DD088E96E604Q40841454-D198B65A-F7F6-45C1-B122-6F91D6F00292Q47553894-F01A3325-0A9B-4B06-AEBA-E542EFD8D889Q47601905-3A7E8C37-0007-4C2C-9EBA-E75620E820BBQ54216735-DB07257E-86D6-45A1-9EE2-7EAAA3494377Q55393682-BCF87645-0535-430F-B2FE-1D99AA792379
P2860
Genome-free hepatitis B virion levels in patient sera as a potential marker to monitor response to antiviral therapy.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Genome-free hepatitis B virion ...... response to antiviral therapy.
@ast
Genome-free hepatitis B virion ...... response to antiviral therapy.
@en
type
label
Genome-free hepatitis B virion ...... response to antiviral therapy.
@ast
Genome-free hepatitis B virion ...... response to antiviral therapy.
@en
prefLabel
Genome-free hepatitis B virion ...... response to antiviral therapy.
@ast
Genome-free hepatitis B virion ...... response to antiviral therapy.
@en
P2093
P2860
P356
P1476
Genome-free hepatitis B virion ...... response to antiviral therapy.
@en
P2093
K M Kitrinos
L Luckenbaugh
W E Delaney
P2860
P304
P356
10.1111/JVH.12361
P577
2014-11-14T00:00:00Z